David et al. (2026)
- Authors: Kandarp K. David, Shaida A. Andrabi, Guy G. Poirier, Valina L. Dawson, Ted M. Dawson
- Institutes: Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, USA, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA, Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, USA
- Publisher: Journal of Biological Chemistry
- Link: DOI
Summary
This research reveals a critical mechanism by which SARS-CoV-2 directly compromises cellular energy production by hijacking mitochondria. By identifying the specific viral protein responsible for metabolic ‘rewiring,’ the study opens new avenues for therapeutic targets that could prevent the cellular exhaustion and oxidative stress associated with both acute COVID-19 and potentially long-term post-viral syndromes like ME/CFS.
What was researched?
The study investigated how the SARS-CoV-2 envelope (E) protein interacts with host cell mitochondria and its subsequent impact on cellular metabolism and structural integrity.
Why was it researched?
While the E protein is known for viral assembly, researchers sought to understand its role in host cell dysfunction, specifically how it contributes to the metabolic and redox imbalances observed in infected patients.
How was it researched?
Scientists used fluorescence microscopy to track protein localization, lipidomic and metabolomic profiling to measure chemical changes, and Seahorse flux analysis to evaluate mitochondrial respiration in E-expressing cells.
What has been found?
The E protein localizes to mitochondria, causing a significant reduction in cardiolipin 💊 and other essential lipids while disrupting the electron transport chain. This leads to decreased membrane potential, increased reactive oxygen species (ROS) retention, and a shift in metabolism toward aerobic glycolysis characterized by depleted TCA cycle intermediates.
Discussion
The findings suggest that the E protein acts as a metabolic disruptor that facilitates viral replication by shifting energy resources. Although it induces high oxidative stress, it notably does not trigger immediate cell death, allowing the virus to exploit the host cell longer.
Conclusion & Future Work
The SARS-CoV-2 E protein is a major driver of mitochondrial dysfunction and metabolic reprogramming. Future research should focus on blocking its mitochondrial targeting to mitigate systemic host damage.